corner-l-sm-grey

Leading the field of
Optoacoustic Imaging

corner-r-sm-grey

Leading the field of
Optoacoustic
Imaging

How can optoacoustic imaging benefit you?

Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications, for both clinical and preclinical research.
Following the success of OAI in preclinical research, the technology has already transitioned into clinical research use. Key areas of interest include oncology, inflammation and fibrosis. Results obtained so far support a bright future for OAI in clinical diagnosis.
In the past 5-10 years, OAI has become an established imaging modality for in vivo preclinical research. Based on its unique ability to differentiate endogenous chromophores and exogenous probes, a wide variety of applications has been successfully explored.

How can optoacoustic imaging benefit you?

Due to its spatiotemporal resolution, penetration depth, sensitivity and specificity, optoacoustic imaging (OAI) can be used for a multitude of applications, for both clinical and preclinical research.
Following the success of OAI in preclinical research, the technology has already transitioned into clinical research use. Key areas of interest include oncology, inflammation and fibrosis. Results obtained so far support a bright future for OAI in clinical diagnosis.
In the past 5-10 years, OAI has become an established imaging modality for in vivo preclinical research. Based on its unique ability to differentiate endogenous chromophores and exogenous probes, a wide variety of applications has been successfully explored.

Upcoming Events

07.12.2022 - 09.12.2022 // Vancouver (Canada)
19.01.2023 - 21.01.2023 // Denver (USA)
01.03.2023 - 04.03.2023 // Copenhagen (Denmark)
14.03.2023 - 17.03.2023 // Salzburg (Austria)

Upcoming Events

07.12.2022 - 09.12.2022 // Vancouver (Canada)
19.01.2023 - 21.01.2023 // Denver (USA)
01.03.2023 - 04.03.2023 // Copenhagen (Denmark)
14.03.2023 - 17.03.2023 // Salzburg (Austria)

Latest News

iThera Medical reports initiation of fifth clinical site in ongoing study for the non-invasive assessment of inflammatory bowel disease

October 18, 2022

Munich, DE – Medical device company iThera Medical announces that the fifth site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD).

iThera Medical leads €1.6m project to develop novel machine learning-assisted optoacoustic imaging of neuromuscular disease

May 17, 2022

Medical device company iThera Medical announces the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation. Commenced on 01 May 2022, the project aims to develop an innovative new approach to monitor neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image reconstruction assisted by machine learning.

Recent Webinars

Contact us

If you have any questions about our technology, applications or products, don’t hesitate to get in touch.

+49 (0) 89 700 7449-21

Address Zielstattstrasse 13, 81379 Munich, Germany

Email info@ithera-medical.com